Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean propionibacterium acid?
Displaying drugs 9476 - 9500 of 10081 in total
Nutraceutical
Nutraceutical
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Experimental
Lucitanib has been used in trials studying the treatment of ER+, MBC, SCLC, HER2+, and NSCLC, among others.
Investigational
Indiplon has been used in trials studying the treatment of Insomnia and Depression.
Investigational
Grapiprant, also known as AT-001 and CJ-023, is a drug from the piprant class. These molecules were derived from acylsulfonamide and are characterized to be a novel series of para-N-acylaminomethylbenzoic acid known to be prostaglandin receptor antagonists. This type of molecules is currently in development for veterinary patients. This class...
Investigational
Vet approved
Nimustine has been used in trials studying the treatment of Glioblastoma.
Investigational
Experimental
Experimental
Pipamperone is a typical antipsychotic of the butyrophenone family used in the treatment of schizophrenia. It was developed by Janssen Pharmaceutica in 1961 and started its first round of clinical trials in 1963 [L1514, L1518]. In an effort to improve haloperidol's pharmacological effects, Janssen discovered that pipamperone, an agent whose...
Investigational
Fanapanel has been investigated for the treatment of Visual Acuity.
Investigational
PAC-1 has been used in trials studying the treatment of Lymphoma, Melanoma, Solid Tumors, Breast Cancer, and Thoracic Cancers, among others.
Investigational
Experimental
Displaying drugs 9476 - 9500 of 10081 in total